These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12832061)

  • 1. The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 protein.
    Shats I; Milyavsky M; Erez N; Rotter V
    FEBS Lett; 2003 Jul; 546(2-3):321-4. PubMed ID: 12832061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
    Wolkowicz R; Elkind NB; Ronen D; Rotter V
    Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA.
    Herkel J; Erez-Alon N; Mimran A; Wolkowicz R; Harmelin A; Ruiz P; Rotter V; Cohen IR
    Eur J Immunol; 2000 Apr; 30(4):977-84. PubMed ID: 10760784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNA.
    Herkel J; Kam N; Erez N; Mimran A; Heifetz A; Eisenstein M; Rotter V; Cohen IR
    Eur J Immunol; 2004 Dec; 34(12):3623-32. PubMed ID: 15495163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice.
    Yuan X; Ishibashi S; Hatakeyama S; Saito M; Nakayama J; Nikaido R; Haruyama T; Watanabe Y; Iwata H; Iida M; Sugimura H; Yamada N; Ishikawa F
    Genes Cells; 1999 Oct; 4(10):563-72. PubMed ID: 10583505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis.
    Lee MK; Hande MP; Sabapathy K
    J Cell Sci; 2005 Feb; 118(Pt 4):819-29. PubMed ID: 15687103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
    Legros Y; Meyer A; Ory K; Soussi T
    Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-chain antibody against the common epitope of mutant p53: isolation and intracytosolic expression in mammalian cells.
    Govorko D; Cohen G; Solomon B
    J Immunol Methods; 2001 Dec; 258(1-2):169-81. PubMed ID: 11684134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.
    Otvos L; Hoffmann R; Xiang ZQ; O I; Deng H; Wysocka M; Pease AM; Rogers ME; Blaszczyk-Thurin M; Ertl HC
    Biochim Biophys Acta; 1998 Sep; 1404(3):457-74. PubMed ID: 9739174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
    Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
    Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against p53 cross-reacts with processing bodies.
    Thomas MG; Luchelli L; Pascual M; Gottifredi V; Boccaccio GL
    PLoS One; 2012; 7(5):e36447. PubMed ID: 22590546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human telomerase reverse transcriptase sequence containing two antigenic epitopes with high affinity for human leucocyte antigen.
    Wang J; Yu L; Li J; Deng R; Wang X
    Biotechnol Appl Biochem; 2007 Oct; 48(Pt 2):93-9. PubMed ID: 17868023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope analysis of the human p53 tumour suppressor protein.
    Dolezalová H; Vojtĕsek B; Kovarík J
    Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein.
    Orgad S; Goldfinger N; Cohen G; Rotter V; Solomon B
    FEBS Lett; 2005 Oct; 579(25):5609-15. PubMed ID: 16213502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'wildtype' conformation of p53: epitope mapping using hybrid proteins.
    Wang PL; Sait F; Winter G
    Oncogene; 2001 Apr; 20(18):2318-24. PubMed ID: 11402327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide sequence of the porcine p53 cDNA, and the detection of recombinant porcine p53 expressed in vitro with a variety of anti-p53 antibodies.
    Burr PD; Argyle DJ; Reid SW; Nasir L
    Oncogene; 1999 Sep; 18(35):5005-9. PubMed ID: 10490836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mouse telomerase catalytic subunit in embryos and adult tissues.
    Martín-Rivera L; Herrera E; Albar JP; Blasco MA
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10471-6. PubMed ID: 9724727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new set of monoclonal antibodies directed to proline-rich and central regions of p53.
    Voeltzel T; Morel AP; Rostan MC; Ji J; Chiodino C; Ponchel F; Vigouroux J; Caron de Fromentel C; Soussi T; Ozturk M
    Hybrid Hybridomics; 2004 Oct; 23(5):287-92. PubMed ID: 15672606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.